Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization”
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 4
Abstract
The use of nanotechnology in medicine holds great promise for revolutionizing a variety of therapies. The past decade witnessed dramatic advancements in scientific research in nanomedicines, although significant challenges still exist in nanomedicine design, characterization, development, and manufacturing. In March 2013, a two-day symposium “Nanomedicines: Charting a Roadmap to Commercialization,” sponsored and organized by the Nanomedicines Alliance, was held to facilitate better understanding of the current science and investigative approaches and to identify and discuss challenges and knowledge gaps in nanomedicine development programs. The symposium provided a forum for constructive dialogue among key stakeholders in five distinct areas: nanomedicine design, preclinical pharmacology, toxicology, CMC (chemistry, manufacturing, and control), and clinical development. In this meeting synopsis, we highlight key points from plenary presentations and focus on discussions and recommendations from breakout sessions of the symposium.
Authors and Affiliations
Gregory Finch, Henry Havel, Mostafa Analoui, Randall W. Barton, Anil R. Diwan, Meliessa Hennessy, Vijayapal Reddy, Nakissa Sadrieh, Lawrence Tamarkin, Marc Wolfgang, Benjamin Yerxa, Banu Zolnik, Man Liu
Keywords
Related Articles
- EP ID EP681719
- DOI 10.1208/s12248-014-9608-5
- Views 65
- Downloads 0
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
The online version of this article (doi:10.1208/s12248-012-9343-8) contains supplementary material, which is available to authorized users.
Issues and Challenges of Subvisible and Submicron Particulate Analysis in Protein Solutions
The online version of this article (doi:10.1208/s12248-012-9335-8) contains supplementary material, which is available to authorized users.
Flow Imaging Microscopy for Protein Particle Analysis—A Comparative Evaluation of Four Different Analytical Instruments
The online version of this article (doi:10.1208/s12248-013-9522-2) contains supplementary material, which is available to authorized users.
Effect of multivariate process instability on principal component analysis: A case study
With the rising use of principal component analysis/partial least squares (PCA/PLS) in the process analytical technology (PAT) initiative of the pharmaceutical industry, it seems appropriate to view that approach from a...
Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans
To investigate the potential added value of intranasal drug administration, preclinical studies to date have typically used the area under the curve (AUC) in brain tissue or cerebrospinal fluid (CSF) compared to plasma f...